Germany Respiratory Drug Market Size, Industry Trends, Share and Forecast 2019-2025
Germany respiratory drug market was valued more than $3.0 billion in 2018 and is anticipated to grow at a substantial rate of 7.2% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in the country. Moreover, the presence of market players in the country is also influencing the market growth of the country. For instance, Ingelheim-based Boehringer Ingelheim International GmbH collaborated with Weill Cornell Medicine in February 2017. The aim of the collaboration is to find new treatment approaches for chronic pulmonary diseases. The three-year collaboration aimed to develop novel treatments that could stop and deteriorate the progression of COPD.
To Request a Sample of our Report on Germany
Respiratory Drug Market: https://www.omrglobal.com/request-sample/germany-respiratory-drug-market
The Germany respiratory drug market is segmented on the basis
of the route of administration, application, and end-user. Based on the route
of administration, the market is classified into oral, injectable, and
inhalable. Moreover, on the basis of application, the market has been
classified into asthma and COPD diseases. The asthma disease application
segment dominated the regional market in 2018 and is further estimated to
follow the same trend over the forecast period. This is mainly due to the high
prevalence of asthma in the country. In addition, based on the end-user,
homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of Germany Respiratory Drug Market is Available @ https://www.omrglobal.com/industry-reports/germany-respiratory-drug-market
Germany Respiratory Drug Market Segmentation
By Route of Administration
·
Oral
·
Injectable
·
Inhalable
·
France Respiratory Drug Market by Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
Air Liquide S.A.
·
Aradigm Corp.
·
AstraZeneca PLC
·
Baxter International Inc.
·
Boehringer Ingelheim International GmbH
·
F. Hoffmann-La Roche Ltd.
·
GlaxoSmithKline PLC
·
Merck & Co.
·
Novartis AG
·
Omron Healthcare Inc.
·
Pfizer Inc.
·
Pulmatrix Inc.
·
ResMed Corp.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Takeda Pharmaceutical Company Ltd.
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment